INDO-MIM Limited (INDOMIM)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2FY27 revenue INR1,271 Cr, up from INR1,218 Cr in Q1; H1FY27 revenue INR2,490 Cr, +INR263 Cr y-y
- EBITDA margin 32% in H1FY27, +6.3% y-y; PAT INR455 Cr, +INR160 Cr y-y (excl. exceptional items, PAT stable)
- ROCE 36.5%, ROE 26.3%, debt-to-equity 0.27, improved leverage
- Aerospace business up 31.5%, automotive 25%, medical 19%, defense growing; electronic component manufacturing down 40%
- FY27 guidance: INR5,000 Cr revenue target on track; PAT guidance INR850 Cr, update in Q3
- Capex focused on secondary operations; no major primary process capex
- Inorganic growth: exploring acquisitions in Europe and US; greenfield plans if acquisitions don't materialize
- Multiple analyst queries on growth outlook in aerospace, IGT, humanoid robots, private satellites; management confident on medium-term growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDOMIM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDOMIM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on INDO-MIM Limited
Important.
The summary above is generated automatically from INDO-MIM Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.